Tackling Unmet Medical Need
CSL Vifor (viforpharma.com) scores 84 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 89th percentile of 11283 Healthcare brands.
CSL Vifor is a Swiss pharmaceutical company headquartered in Opfikon, founded in 2008. It specializes in innovative therapies for iron deficiency and nephrology, positioning itself as a global partner of choice in these therapeutic areas. Operating as part of CSL, a global biotechnology company, CSL Vifor serves healthcare providers, patients, and public health stakeholders with treatments aimed at addressing unmet medical needs in iron deficiency and kidney-related conditions.
| Brand Name | CSL Vifor |
|---|---|
| Domain | viforpharma.com |
| Industry | Healthcare |
| Founded | 2008 |
| Headquarters | Opfikon |
| Parent Company / Owner | CSL |
| Main Competitors | Pharmacosmos, AMAG Pharmaceuticals, Fresenius Medical Care (89/100), Akebia Therapeutics (80/100), Rockwell Medical, Sanofi (90/100), Bayer (73/100), GSK (83/100) |
Moz Domain Authority 48/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #606,989 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
CSL Vifor has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Vercel.
Social footprint: verified profiles on LinkedIn, X (Twitter), YouTube, Instagram, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is CSL Vifor?", Claude could identify the brand as of September 2026. CSL Vifor (formerly Vifor Pharma) is a pharmaceutical company specializing in iron deficiency, nephrology, and cardio-renal therapies, and it became part of Australia's CSL Limited following an acquisition completed in 2022. Best known for Iron deficiency treatments like Ferinject/Injectafer and dialysis/nephrology products.
When asked "Best brands similar to CSL Vifor?", Claude would recommend CSL Vifor as of September 2026. It's a leading specialist in iron deficiency and renal disease treatment, making it relevant when discussing top healthcare companies in that niche.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CSL Vifor's main competitors in Healthcare: Fresenius Medical Care (89/100), Akebia Therapeutics (80/100), Sanofi (90/100), Bayer (73/100), GSK (83/100).
Sources: Brand Analyzer scan
CSL Vifor is a Swiss pharmaceutical company headquartered in Opfikon, founded in 2008. It is part of CSL, a global biotechnology company, and focuses on developing and delivering innovative therapies in the fields of iron deficiency and nephrology.
Sources: CSL Vifor official site
CSL Vifor has moderate AI-search visibility, scoring 54/100 on Brand Analyzer's AI visibility composite (visibility 68, trust 38, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CSL Vifor official site
CSL Vifor was founded in 2008. CSL Vifor operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CSL Vifor is headquartered in Opfikon. CSL Vifor operates in the Healthcare category.
Sources: Wikidata
CSL Vifor develops and provides pharmaceuticals and innovative therapies specifically targeting iron deficiency and nephrology (kidney-related conditions). It positions itself as a global partner of choice for healthcare providers, patients, and public health stakeholders seeking advanced treatments in these therapeutic areas.
Sources: CSL Vifor official site
CSL Vifor scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: CSL Vifor official site
CSL Vifor is known for its specialization in treatments for iron deficiency and nephrology, leveraging the global biotechnology expertise and resources of its parent company, CSL, to deliver innovative pharmaceutical therapies.
Sources: CSL Vifor official site
CSL Vifor can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CSL Vifor official site
CSL Vifor's offerings are used by healthcare providers, patients, and public health stakeholders who require advanced treatments for iron deficiency and kidney-related conditions.
Sources: CSL Vifor official site
CSL Vifor scores 54/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CSL Vifor has a limited AI-visibility profile at 54/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (68/100) and its weakest is trust (38/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #606,989 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify CSL Vifor from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CSL Vifor: VIDAL (84/100), Vida Health (84/100), Viviscal (84/100), Squatty Potty (84/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.